Dr Rashmi Chugh from Rogel Comprehensive Cancer Center in Ann Arbor, Michigan, and Dr Mrinal Gounder from Memorial Sloan Kettering Cancer Center in New York, New York, summarize major clinical findings presented at the 2025 ASCO Annual Meeting for patients with soft tissue sarcoma and other connective tissue neoplasms. 

CME information and select publications here.

Clinical investigators discuss available data guiding the management of sarcoma and other connective tissue neoplasms.  

CME information and select publications here.

Dr Christopher L Moertel from the University of Minnesota in Minneapolis discusses the clinical presentation of and optimal management strategies for plexiform neurofibromas and malignancies associated with neurofibromatosis type 1. 

CME information and select publications here.

Dr Emanuela Palmerini from the IRCCS Istituto Ortopedico Rizzoli in Bologna, Italy, discusses the current and future clinical treatment of tenosynovial giant cell tumor.

Dr Mrinal Gounder from Memorial Sloan Kettering Cancer Center in New York, New York, discusses recent updates on available and emerging treatment strategies for dedifferentiated liposarcoma and other sarcomas.

Dr Evan J Lipson from the Sidney Kimmel Comprehensive Cancer Center in Baltimore, Maryland, summarizes major clinical advances over the past year for treating skin cancers.

Dr Nikhil I Khushalani from Moffitt Cancer Center in Tampa, Florida and Dr Jason J Luke from UPMC Hillman Cancer Center in Pittsburgh, Pennsylvania discuss recently presented findings from ASCO on the management of melanoma and nonmelanoma skin cancers.

Dr Nikhil Khushalani from the Moffitt Cancer Center in Tampa, Florida, and Dr Anna Pavlick from the Weill Cornell Medicine Meyer Cancer Center in New York, New York, discuss available and novel treatment strategies for cutaneous squamous cell carcinoma and basal cell carcinoma.

Prof Georgina Long from the University of Sydney in Sydney, New South Wales, Australia, discusses optimizing the management of melanoma, moderated by Dr Neil Love.

Featuring a discussion on the most impactful updates from 2022 in the management of melanoma and nonmelanoma skin cancers with Dr Omid Hamid and Dr Evan J Lipson, moderated by Dr Neil Love.